Daiichi Sankyo Inks Clinical Research Collaboration With Merck

Daiichi Sankyo Inks Clinical Research Collaboration With Merck

By, Admin 4 June 2020

Japan Based Daiichi Sankyo Company, Limited Announced That It Has Entered Into A Clinical Trial Collaboration Agreement With A Subsidiary Of Merck &Amp; Co., Inc., Kenilworth, New Jersey, U.S.A., Known As Msd Outside The United States And Canada, To Evaluate The Combination Of Ds-1062, A Trop2 Directed Dxd Antibody Drug Conjugate (Adc), And Keytruda&Reg; (Pembrolizumab) In Patients With Previously-Treated Advanced Or Metastatic Non-Small Cell Lung Cancer (Nsclc) Without Actionable Genomic Alterations.Trop2 (Trophoblast Cell-Surface Antigen 2) Is A Transmembrane Glycoprotein That Is Overexpressed In Many Cancers; High Trop2 Expression Has Been Identified In A Majority Of Nsclcs.Under The Terms Of The Agreement, Daiichi Sankyo Will Conduct A Multicenter, Two-Part, Open-Label, Non-Randomized, Phase 1B Study Of Ds-1062 In Combination With Keytruda In Patients With Advanced Or Metastatic Nsclc Without Actionable Genomic Alterations And Previously Treated With Platinum-Based Chemotherapy With Or Without Immunotherapy.Ds-1062 Is One Of Three Lead Dxd Antibody Drug Conjugates (Adcs) In The Oncology Pipeline Of Daiichi Sankyo.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!